Alphabet Inc.
Total reported value
$4.0B
Reporting period: 2026-03-31 · Number of holdings: 27
Alphabet Inc. disclosed 27 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $4.0B and a quarterly turnover rate of 61.0%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "A"
Personality snowflake
- Concentration
- 69.79
- Portfolio Stability
- 60.98
- Momentum/Contrarian
- 100
- Sector conviction
- 83.25
- Diversification
- 52
- Sizing Uniformity
- 80.82
Recent moves
Trim ASTS
0.0% $91.6M
Trim FRSH
0.0% -$68.4M
Trim PATH
0.0% -$37.2M
Trim GTLB
0.0% -$43.3M
Trim RVMD
-1.6% $53.8M
Trim TEM
0.0% -$21.5M
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
Showing top 26 holdings (of 27 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CME | Cme Group INC | Stock-Financials | 25.63% | +25.63% | NEW | |
| 2 | PL | Planet Labs Pbc | Stock-Industrials | 24.53% | +0.11% | +10.35% | |
| 3 | ASTS | Ast Spacemobile INC | Stock-Tech | 18.46% | -6.72% | — | |
| 4 | RVMD | Revolution Medicines INC | Stock-Healthcare | 7.97% | -2.36% | -1.57% | |
| 5 | ARM | Arm Holdings Plc-adr | Stock-Tech | 7.39% | -0.92% | — | |
| 6 | FRSH | Freshworks Inc-cl A | Stock-Other | 3.24% | -4.46% | — | |
| 7 | PATH | Uipath INC - Class A | Stock-Tech | 1.94% | -2.53% | — | |
| 8 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 1.75% | -1.80% | — | |
| 9 | PAYP | Paypay CORP | Stock-Other | 1.66% | +1.66% | NEW | |
| 10 | GTLB | Gitlab Inc-cl A | Stock-Tech | 1.47% | -2.49% | — | |
| 11 | PRME | Prime Medicine INC | Stock-Other | 1.44% | -0.79% | — | |
| 12 | LIFE | Ethos Technologies INC Cl-a | Stock-Other | 1.05% | +1.05% | NEW | |
| 13 | MAZE | Maze Therapeutics INC | Stock-Other | 1.03% | -1.20% | — | |
| 14 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 0.63% | -0.74% | — | |
| 15 | RLAY | Relay Therapeutics INC | Stock-Other | 0.39% | -0.12% | -0.29% | |
| 16 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 0.28% | -0.17% | -8.14% | |
| 17 | VERA | Vera Therapeutics INC | Stock-Other | 0.24% | -0.23% | — | |
| 18 | SANA | Sana Biotechnology INC | Stock-Other | 0.20% | -0.24% | — | |
| 19 | BEAM | Beam Therapeutics INC | Stock-Other | 0.19% | -0.16% | — | |
| 20 | LYEL | Lyell Immunopharma INC | Stock-Other | 0.15% | -0.20% | — | |
| 21 | OSCR | Oscar Health INC - Class A | Stock-Healthcare | 0.14% | -0.13% | — | |
| 22 | FIG | Figma Inc-cl A | Stock-Other | 0.11% | -0.20% | — | |
| 23 | SPRO | Spero Therapeutics INC | Stock-Other | 0.05% | -0.03% | — | |
| 24 | HYPR | Hyperfine INC | Stock-Other | 0.02% | -0.01% | — | |
| 25 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.02% | -0.03% | — | |
| 26 | TNYA | Tenaya Therapeutics INC | Stock-Other | 0.02% | -0.01% | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 27 | $4.0B | 61 | |
| 2025-12-31 | 32 | $2.6B | 37 | |
| 2025-09-30 | 40 | $2.4B | 49 | |
| 2025-06-30 | 39 | $2.1B | 0 | |
| 2025-03-31 | 44 | $1.6B | 0 | |
| 2024-12-31 | 44 | $1.7B | 0 | |
| 2024-09-30 | 46 | $1.8B | 0 | |
| 2024-06-30 | 46 | $2.0B | 0 | |
| 2024-03-31 | 47 | $2.5B | 0 | |
| 2023-12-31 | 48 | $2.2B | 0 | |
| 2023-09-30 | 51 | $1.6B | 0 | |
| 2023-06-30 | 56 | $1.9B | 0 | |
| 2023-03-31 | 58 | $1.8B | 0 | |
| 2022-12-31 | 61 | $1.7B | 0 | |
| 2022-09-30 | 59 | $2.0B | 0 | |
| 2022-06-30 | 65 | $1.8B | 0 | |
| 2022-03-31 | 70 | $3.1B | 0 | |
| 2021-12-31 | 67 | $4.1B | 0 | |
| 2021-09-30 | 52 | $4.2B | 0 | |
| 2021-06-30 | 44 | $4.9B | — | |
| 2021-03-31 | 37 | $2.5B | — | |
| 2020-12-31 | 33 | $2.1B | — | |
| 2020-09-30 | 26 | $2.1B | — | |
| 2020-06-30 | 26 | $2.2B | — | |
| 2020-03-31 | 28 | $1.5B | — | |
| 2019-12-31 | 27 | $1.7B | — | |
| 2019-09-30 | 27 | $3.3B | — | |
| 2019-06-30 | 26 | $5.3B | — | |
| 2019-03-31 | 19 | $1.9B | — | |
| 2018-12-31 | 18 | $845.8M | — | |
| 2018-09-30 | 17 | $1.0B | — | |
| 2018-06-30 | 17 | $1.2B | — | |
| 2018-03-31 | 11 | $614.8M | — | |
| 2017-12-31 | 8 | $368.6M | — | |
| 2017-09-30 | 4 | $344.0M | — | |
| 2017-06-30 | 4 | $347.4M | — | |
| 2017-03-31 | 3 | $316.8M | — | |
| 2016-12-31 | 2 | $292.8M | — | 1G0551A2TWTRUSD |
| 2016-09-30 | 2 | $275.2M | — | 1G0551A2LCEUR |
| 2016-06-30 | 3 | $209.8M | — | |
| 2016-03-31 | 5 | $242.9M | — | |
| 2015-12-31 | 6 | $326.8M | — | |
| 2015-09-30 | 7 | $416.1M | — | |
| 2015-06-30 | 7 | $482.2M | — | |
| 2015-03-31 | 6 | $601.0M | — | |
| 2014-12-31 | 7 | $659.6M | — | |
| 2014-09-30 | 4 | $304.5M | — | |
| 2014-06-30 | 4 | $383.2M | — | |
| 2014-03-31 | 3 | $381.2M | — | |
| 2013-12-31 | 4 | $365.1M | — | 104270V2350465376132B |
Holding changes this quarter
Alphabet Inc.'s most significant position changes for 2026-03-31: New buy: Cme Group INC (CME); Sold out: Dexcom INC (DXCM); New buy: Paypay CORP (PAYP); New buy: Ethos Technologies INC Cl-a (LIFE); Sold out: Genedx Holdings CORP (WGS).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PL | Planet Labs Pbc | +0.1% | +10.35% | Add |
| 2 | HYPR | Hyperfine INC | 0% | — | Unchanged |
| 3 | TNYA | Tenaya Therapeutics INC | 0% | — | Unchanged |
| 4 | AUTL | Autolus Therapeutics PLC | 0% | — | Unchanged |
| 5 | SPRO | Spero Therapeutics INC | 0% | — | Unchanged |
| 6 | RLAY | Relay Therapeutics INC | -0.1% | -0.29% | Trim |
| 7 | OSCR | Oscar Health INC - Class A | -0.1% | — | Unchanged |
| 8 | BEAM | Beam Therapeutics INC | -0.2% | — | Unchanged |
| 9 | GLUE | Monte Rosa Therapeutics INC | -0.2% | -8.14% | Trim |
| 10 | FIG | Figma Inc-cl A | -0.2% | — | Unchanged |
| 11 | LYEL | Lyell Immunopharma INC | -0.2% | — | Unchanged |
| 12 | VERA | Vera Therapeutics INC | -0.2% | — | Unchanged |
| 13 | SANA | Sana Biotechnology INC | -0.2% | — | Unchanged |
| 14 | BBOT | Bridgebio Oncology Therapeut | -0.7% | — | Unchanged |
| 15 | PRME | Prime Medicine INC | -0.8% | — | Unchanged |
| 16 | ARM | Arm Holdings Plc-adr | -0.9% | — | Unchanged |
| 17 | MAZE | Maze Therapeutics INC | -1.2% | — | Unchanged |
| 18 | TEM | Tempus Ai Inc-cl A | -1.8% | — | Unchanged |
| 19 | RVMD | Revolution Medicines INC | -2.4% | -1.57% | Trim |
| 20 | GTLB | Gitlab Inc-cl A | -2.5% | — | Unchanged |
| 21 | PATH | Uipath INC - Class A | -2.5% | — | Unchanged |
| 22 | FRSH | Freshworks Inc-cl A | -4.5% | — | Unchanged |
| 23 | ASTS | Ast Spacemobile INC | -6.7% | — | Unchanged |
| 24 | CME | Cme Group INC | — | NEW | New buy |
| 25 | DXCM | Dexcom INC | — | EXIT | Sold out |
| 26 | PAYP | Paypay CORP | — | NEW | New buy |
| 27 | LIFE | Ethos Technologies INC Cl-a | — | NEW | New buy |
| 28 | WGS | Genedx Holdings CORP | — | EXIT | Sold out |
| 29 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 30 | QNCX | Quince Therapeutics, Inc. | — | EXIT | Sold out |
| 31 | FULC | Fulcrum Therapeutics INC | — | EXIT | Sold out |
| 32 | RGEN | Repligen CORP | — | EXIT | Sold out |
FAQ
What is Alphabet Inc. and what type of investor is it?
What are Alphabet Inc.'s largest equity positions?
What changes did Alphabet Inc. make in its most recent portfolio filing?
What sectors does Alphabet Inc. focus on?
Peer Institutions
Institutions with a similar AUM
Arbejdsmarkedets Tillaegspension
Total reported value
$4.0B
169 stks
2026-03-31
AUM within 0.1% of this institution
Journey Strategic Wealth LLC
Total reported value
$4.0B
3,980 stks
2026-03-31
AUM within 0.3% of this institution
Cary Street Partners Financial LLC
Total reported value
$4.0B
1,357 stks
2026-03-31
AUM within 0.5% of this institution
Similar Holdings Style
Institutions with overlapping top holdings
Cincinnati Financial CORP
Total reported value
$5.0B
55 stks
2026-03-31
1 of the top 5 holdings overlap, including Cme Group INC
Bp PLC
Total reported value
$17.7M
1 stks
2026-03-31
1 of the top 5 holdings overlap, including Cme Group INC
Mufg Bank, LTD.
Total reported value
$3.0B
5 stks
2026-03-31
1 of the top 5 holdings overlap, including Cme Group INC